NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Aayush Wellness Shares Surge 9% in Thursday's Trade

On Thursday, 24 April, shares of Aayush Wellness jumped 9% in a significant turnaround, reaching a three-month high of ₹39 apiece. This marked the second consecutive session of gains, with the stock's two-day cumulative rise reaching 21%. Despite the broader market sell-off, the stock defied the trend and continued its upward trajectory.

The company's stock traded around one million shares on both the BSE and NSE by the end of the session. Aayush Wellness' recent announcement of a new product launch is believed to have contributed to the stock's surge. The company has announced the launch of a new advanced herbal formulation designed to naturally detoxify, protect, and regenerate liver cells, addressing growing liver health concerns driven by modern lifestyle habits, environmental toxins, and poor dietary choices.

The new product launch is part of the company's continued effort to expand its preventive healthcare portfolio. Aayush Wellness has recently expanded its product portfolio across Herbal Masala, Beauty Gummies, Sleep Gummies, Lung Care Tablets, and now Liver Care Tablets, demonstrating a scalable platform approach to consumer healthcare innovation.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

ProductLaunch Date
Herbal MasalaN/A
Beauty GummiesN/A
Sleep GummiesN/A
Lung Care TabletsN/A
Liver Care TabletsN/A

The Indian nutraceutical market, currently estimated at around $18 billion, is witnessing strong double-digit growth, supported by rising health awareness, increasing disposable incomes, and a shift toward preventive healthcare. Aayush Wellness is strategically positioning itself to capture emerging opportunities by expanding its product range and strengthening its presence in high-growth wellness categories.

Commenting on the launch, Naveenakumar, Managing Director of Aayush Wellness Limited, said, "Liver health remains an under-addressed yet critical component of overall well-being. With our Liver Care Tablets, we aim to offer a preventive solution that empowers individuals to proactively manage their health." By integrating Ayurvedic wisdom with clinically validated ingredients, the company is building solutions that are both effective and aligned with evolving consumer preferences.

Aayush Wellness' share price trend has been volatile in recent months. After remaining under pressure since July 2025, the stock has staged a strong turnaround in April, rebounding 41.2% and offering much-needed relief to shareholders who had been awaiting a recovery for nearly a year. The shares came under severe selling pressure after hitting a peak of ₹267 in July, entering a prolonged correction and falling to as low as ₹26 in recent months.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

The decline followed a stellar rally between November 2023 and June 2025, during which the stock surged from ₹2.13 to ₹203, delivering a massive gain of around 9,500%. On a yearly basis, the stock delivered an exceptional return of 3,219% in CY24 alone, marking its strongest annual performance since listing. Cumulatively, the stock is up nearly 3,000% over the past three years and around 2,000% over the last five years.

Investor Takeaway

Investors should monitor Aayush Wellness Limited for potential long-term growth opportunities in the preventive healthcare sector.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.